0000000000077343

AUTHOR

Asier Eguia

showing 3 related works from this author

Are mucous retention cysts and pseudocysts in the maxillary sinus a risk factor for dental implants? A systematic review

2020

Background Mucous retention cysts and pseudocysts of the maxillary sinus are benign lesions present in up to 13% of adult patients. Different surgical approaches for sinus lift and dental implant placement in the presence of these lesions have been proposed. Material and Methods A systematic review was performed following the PRISMA statement recommendations to answer the PICO question: Does the aspiration or removal of mucous retention cysts/pseudocysts before or during sinus lifting and dental implant placing, affect the survival of the implants? The study was pre-registered in PROSPERO (CRD42020185528). Included articles quality was assessed using the “NIH quality assessment tool” and “T…

AdultMalemedicine.medical_specialtyMaxillary sinusAdolescentRetention Cystmedicine.medical_treatmentSinus liftReviewpigmented lesionsLesionYoung AdultRisk FactorsMedicineHumanspigmentationProspective StudiesProspective cohort studyDental implantChildGeneral DentistrySinus (anatomy)UNESCO:CIENCIAS MÉDICASAgedAged 80 and overDental Implantsbusiness.industryMucous retention cystDental Implantation EndosseousMaxillary SinusMiddle Agedamalgammedicine.diseaseSurgerymelaninmedicine.anatomical_structureOtorhinolaryngologySurgeryFemaleoral cavitymedicine.symptombusinessImplantology
researchProduct

Candida albicans biofilms on different materials for manufacturing implant abutments and prostheses

2019

[EN] Background: Morphological, physical and chemical properties of both implants and prostheses can determine the biofilm formation on their surface and increase the risk of biological complications. The aim of this study was to evaluate the capacity of biofilm formation of Candida albicans on different materials used to manufacture abutments and prostheses. Material and Methods: Biofilm formation was analyzed on cp grade II titanium, cobalt-chromium alloy and zirconia, silicone, acrylic resin (polymethylmethacrylate) and nano-hybrid composite. Some samples were partially covered with lithium disilicate glass ceramic to study specifically the junction areas. C. albicans was incubated in a …

Materials scienceSurface Propertieschemistry.chemical_elementcobalt-chromium alloy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSiliconedental implantsCandida albicansCubic zirconiaCeramictitaniumComposite materialCandida albicansGeneral DentistryAcrylic resinDental ImplantsTitaniumbiologyResearchBiofilmtechnology industry and agriculture030206 dentistrybiochemical phenomena metabolism and nutritionbiology.organism_classificationequipment and supplies:CIENCIAS MÉDICAS [UNESCO]Otorhinolaryngologychemistryvisual_artBiofilmsUNESCO::CIENCIAS MÉDICASvisual_art.visual_art_mediumMicroscopy Electron ScanningSurgeryImplantImplantologyzirconiaTitanium
researchProduct

Review and update on drugs related to the development of osteonecrosis of the jaw

2019

Conflict of interest Conclusions of the working group on “New drugs related to the de-velopment of osteonecrosis of the jaw”. Spanish Society of Cranio-mandibular Dysfunction and Orofacial Pain and Spanish Society of Oral Medicine SEDCYDO-SEMO joint International Meeting: 30th SEDCYDO annual meeting & 15th SEMO Congress. Bilbao (Spain); June, 2019. [EN] Background: Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but serious adverse effect of cer-tain drugs, of which bisphosphonates are the most widely known. This pathology is also associated with other medications such as the biologic antiresorptive agent, denosumab and some antiangiogenics such as sunitinib, bevacizumab or a…

medicine.medical_specialtyBevacizumabReviewMRONJ03 medical and health sciencesantiresorptives0302 clinical medicinemedicineHumansIntensive care medicineAdverse effectGeneral DentistrybisphosphonatesAfliberceptBisphosphonate-associated osteonecrosis of the jawOral Medicine and PathologyBone Density Conservation AgentsDiphosphonatesbusiness.industrySunitinibOsteonecrosis030206 dentistryEvidence-based medicinemedicine.disease:CIENCIAS MÉDICAS [UNESCO]osteonecrosis of the jawantiangiogenicsDenosumabOtorhinolaryngologyPharmaceutical PreparationsUNESCO::CIENCIAS MÉDICASSurgeryBisphosphonate-Associated Osteonecrosis of the JawDenosumabbusinessOsteonecrosis of the jawmedicine.drug
researchProduct